Chinese tech stocks, Commodities outlook, Health care in 2022

Chinese tech stocks have been slammed this year, on fears of regulation and uncertainty out of Beijing. James Liu of Clearnomics joins to discuss why he is still bullish on the sector for U.S. investors, despite regulatory headwinds. Plus, Citi’s Global Head of Commodities Research, Ed Morse, joins Worldwide Exchange to discuss his outlook for the sector. And we discuss the performance of biotech and health care stocks this year, and what to expect from the market next year.